Results
|
|
81.
|
Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey. [electronic resource] by
- Paillaud, E
- Soubeyran, P
- Caillet, P
- Cudennec, T
- Brain, E
- Terret, C
- Etchepare, F
- Mourey, L
- Aparicio, T
- Pamoukdjian, F
- Audisio, R A
- Rostoft, S
- Hurria, A
- Bellera, C
- Mathoulin-Pélissier, S
Producer: 20190520
In:
European journal of cancer (Oxford, England : 1990) vol. 103
Availability: No items available.
|
|
|
82.
|
Structure--activity relationships in cephalosporins prepared from penicillins. 2. Analogues of cephalexin substituted in the 3-methyl group. [electronic resource] by
- Brain, E G
- Eglington, A J
- James, B G
- Nayler, J H
- Osborne, N F
- Pearson, M J
- Smale, T C
- Southgate, R
- Tolliday, P
- Basker, M J
- Mizen, L W
- Sutherland, R
Producer: 19771028
In:
Journal of medicinal chemistry vol. 20
Availability: No items available.
|
|
|
83.
|
A comparison of limited sampling strategies for prediction of Ecteinascidin 743 clearance when administered as a 24-h infusion. [electronic resource] by
- van Kesteren, C
- Mathĵt, R A
- López-Lázaro, L
- Cvitkovic, E
- Taamma, A
- Jimeno, J M
- Guzman, C
- Schellens, J H
- Misset, J L
- Brain, E
- Hillebrand, M J
- Rosing, H
- Beijnen, J H
Producer: 20020130
In:
Cancer chemotherapy and pharmacology vol. 48
Availability: No items available.
|
|
|
84.
|
Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study. [electronic resource] by
- van Kesteren, C
- Cvitkovic, E
- Taamma, A
- López-Lázaro, L
- Jimeno, J M
- Guzman, C
- Math t, R A
- Schellens, J H
- Misset, J L
- Brain, E
- Hillebrand, M J
- Rosing, H
- Beijnen, J H
Producer: 20010419
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 6
Availability: No items available.
|
|
|
85.
|
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up. [electronic resource] by
- Penel, N
- Le Cesne, A
- Bui, B N
- Perol, D
- Brain, E G
- Ray-Coquard, I
- Guillemet, C
- Chevreau, C
- Cupissol, D
- Chabaud, S
- Jimenez, M
- Duffaud, F
- Piperno-Neumann, S
- Mignot, L
- Blay, J-Y
Producer: 20110502
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
|
86.
|
Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study. [electronic resource] by
- Bonnefoi, H
- Jacot, W
- Saghatchian, M
- Moldovan, C
- Venat-Bouvet, L
- Zaman, K
- Matos, E
- Petit, T
- Bodmer, A
- Quenel-Tueux, N
- Chakiba, C
- Vuylsteke, P
- Jerusalem, G
- Brain, E
- Tredan, O
- Messina, C G M
- Slaets, L
- Cameron, D
Producer: 20160224
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|
|
|
87.
|
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial. [electronic resource] by
- Bonnefoi, H
- Litière, S
- Piccart, M
- MacGrogan, G
- Fumoleau, P
- Brain, E
- Petit, T
- Rouanet, P
- Jassem, J
- Moldovan, C
- Bodmer, A
- Zaman, K
- Cufer, T
- Campone, M
- Luporsi, E
- Malmström, P
- Werutsky, G
- Bogaerts, J
- Bergh, J
- Cameron, D A
Producer: 20150121
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|
|
|
88.
|
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer. [electronic resource] by
- Vrdoljak, E
- Marschner, N
- Zielinski, C
- Gligorov, J
- Cortes, J
- Puglisi, F
- Aapro, M
- Fallowfield, L
- Fontana, A
- Inbar, M
- Kahan, Z
- Welt, A
- Lévy, C
- Brain, E
- Pivot, X
- Putzu, C
- González Martín, A
- de Ducla, S
- Easton, V
- von Minckwitz, G
Producer: 20171226
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|
|
|
89.
|
International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer. [electronic resource] by
- Wheelwright, S
- Darlington, A-S
- Fitzsimmons, D
- Fayers, P
- Arraras, J I
- Bonnetain, F
- Brain, E
- Bredart, A
- Chie, W-C
- Giesinger, J
- Hammerlid, E
- O'Connor, S J
- Oerlemans, S
- Pallis, A
- Reed, M
- Singhal, N
- Vassiliou, V
- Young, T
- Johnson, C
Producer: 20131104
In:
British journal of cancer vol. 109
Availability: No items available.
|
|
|
90.
|
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial. [electronic resource] by
- Ignatiadis, M
- Litière, S
- Rothe, F
- Riethdorf, S
- Proudhon, C
- Fehm, T
- Aalders, K
- Forstbauer, H
- Fasching, P A
- Brain, E
- Vuylsteke, P
- Guardiola, E
- Lorenz, R
- Pantel, K
- Tryfonidis, K
- Janni, W
- Piccart, M
- Sotiriou, C
- Rack, B
- Pierga, J-Y
Producer: 20191223
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|
|
|
91.
|
Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trial. [electronic resource] by
- Valet, F
- de Cremoux, P
- Spyratos, F
- Servant, N
- Dujaric, M E
- Gentien, D
- Lehmann-Che, J
- Scott, V
- Sigal-Zafrani, B
- Mathieu, M C
- Bertheau, P
- Guinebretière, J M
- Pierga, J Y
- Delaloge, S
- Giacchetti, S
- Brain, E
- Tembo, O
- Marty, M
- Asselain, B
Producer: 20141031
In:
Breast (Edinburgh, Scotland) vol. 22
Availability: No items available.
|
|
|
92.
|
Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patients. [electronic resource] by
- Jacquet, E
- Lardy-Cléaud, A
- Pistilli, B
- Franck, S
- Cottu, P
- Delaloge, S
- Debled, M
- Vanlemmens, L
- Leheurteur, M
- Guizard, A V
- Laborde, L
- Uwer, L
- Jacot, W
- Berchery, D
- Desmoulins, I
- Ferrero, J M
- Perrocheau, G
- Courtinard, C
- Brain, E
- Chabaud, S
- Robain, M
- Bachelot, T
Producer: 20190111
In:
European journal of cancer (Oxford, England : 1990) vol. 95
Availability: No items available.
|
|
|
93.
|
An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45. [electronic resource] by
- Bjelic-Radisic, V
- Cardoso, F
- Cameron, D
- Brain, E
- Kuljanic, K
- da Costa, R A
- Conroy, T
- Inwald, E C
- Serpentini, S
- Pinto, M
- Weis, J
- Morag, O
- Lindviksmoen Astrup, G
- Tomaszweksi, K A
- Pogoda, K
- Sinai, P
- Sprangers, M
- Aaronson, N
- Velikova, G
- Greimel, E
- Arraras, J
- Bottomley, A
Producer: 20210106
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 31
Availability: No items available.
|
|
|
94.
|
Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288. [electronic resource] by
- Bjelic-Radisic, V
- Cardoso, F
- Cameron, D
- Brain, E
- Kuljanic, K
- da Costa, R A
- Conroy, T
- Inwald, E C
- Serpentini, S
- Pinto, M
- Weis, J
- Morag, O
- Lindviksmoen Astrup, G
- Tomaszewski, K A
- Pogoda, K
- Sinai, P
- Sprangers, M
- Aaronson, N
- Velikova, G
- Greimel, E
- Arraras, J
- Bottomley, A
Publication details: Annals of oncology : official journal of the European Society for Medical Oncology Apr 2020
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 31
Availability: No items available.
|
|
|
95.
|
Risk estimations and treatment decisions in early stage breast cancer: agreement among oncologists and the impact of the 70-gene signature. [electronic resource] by
- Drukker, C A
- van den Hout, H C
- Sonke, G S
- Brain, E
- Bonnefoi, H
- Cardoso, F
- Goldhirsch, A
- Harbeck, N
- Honkoop, A H
- Koornstra, R H T
- van Laarhoven, H W M
- Portielje, J E A
- Schneeweiss, A
- Smorenburg, C H
- Stouthard, J
- Linn, S C
- Schmidt, M K
Producer: 20140527
In:
European journal of cancer (Oxford, England : 1990) vol. 50
Availability: No items available.
|
|
|
96.
|
Vemurafenib in non-small-cell lung cancer patients with BRAF [electronic resource] by
- Mazieres, J
- Cropet, C
- Montané, L
- Barlesi, F
- Souquet, P J
- Quantin, X
- Dubos-Arvis, C
- Otto, J
- Favier, L
- Avrillon, V
- Cadranel, J
- Moro-Sibilot, D
- Monnet, I
- Westeel, V
- Le Treut, J
- Brain, E
- Trédaniel, J
- Jaffro, M
- Collot, S
- Ferretti, G R
- Tiffon, C
- Mahier-Ait Oukhatar, C
- Blay, J Y
Producer: 20210106
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 31
Availability: No items available.
|
|
|
97.
|
Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study. [electronic resource] by
- Delaloge, S
- Pérol, D
- Courtinard, C
- Brain, E
- Asselain, B
- Bachelot, T
- Debled, M
- Dieras, V
- Campone, M
- Levy, C
- Jacot, W
- Lorgis, V
- Veyret, C
- Dalenc, F
- Ferrero, J M
- Uwer, L
- Kerbrat, P
- Goncalves, A
- Mouret-Reynier, M A
- Petit, T
- Jouannaud, C
- Vanlemmens, L
- Chenuc, G
- Guesmia, T
- Robain, M
- Cailliot, C
Producer: 20180102
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|
|
|
98.
|
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†. [electronic resource] by
- Gourgou-Bourgade, S
- Cameron, D
- Poortmans, P
- Asselain, B
- Azria, D
- Cardoso, F
- A'Hern, R
- Bliss, J
- Bogaerts, J
- Bonnefoi, H
- Brain, E
- Cardoso, M J
- Chibaudel, B
- Coleman, R
- Cufer, T
- Dal Lago, L
- Dalenc, F
- De Azambuja, E
- Debled, M
- Delaloge, S
- Filleron, T
- Gligorov, J
- Gutowski, M
- Jacot, W
- Kirkove, C
- MacGrogan, G
- Michiels, S
- Negreiros, I
- Offersen, B V
- Penault Llorca, F
- Pruneri, G
- Roche, H
- Russell, N S
- Schmitt, F
- Servent, V
- Thürlimann, B
- Untch, M
- van der Hage, J A
- van Tienhoven, G
- Wildiers, H
- Yarnold, J
- Bonnetain, F
- Mathoulin-Pélissier, S
- Bellera, C
- Dabakuyo-Yonli, T S
Producer: 20160519
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|
|
|
99.
|
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). [electronic resource] by
- Gourgou-Bourgade, S
- Cameron, D
- Poortmans, P
- Asselain, B
- Azria, D
- Cardoso, F
- A'Hern, R
- Bliss, J
- Bogaerts, J
- Bonnefoi, H
- Brain, E
- Cardoso, M J
- Chibaudel, B
- Coleman, R
- Cufer, T
- Dal Lago, L
- Dalenc, F
- De Azambuja, E
- Debled, M
- Delaloge, S
- Filleron, T
- Gligorov, J
- Gutowski, M
- Jacot, W
- Kirkove, C
- MacGrogan, G
- Michiels, S
- Negreiros, I
- Offersen, B V
- Penault Llorca, F
- Pruneri, G
- Roche, H
- Russell, N S
- Schmitt, F
- Servent, V
- Thürlimann, B
- Untch, M
- van der Hage, J A
- van Tienhoven, G
- Wildiers, H
- Yarnold, J
- Bonnetain, F
- Mathoulin-Pélissier, S
- Bellera, C
- Dabakuyo-Yonli, T S
Producer: 20160307
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|